EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR ‐mediated epigenetic suppression on VGLL4 by DNMT1

Jing Zhai, Jun-Feng Jiang, Lei Shi iD

The Kaohsiung Journal of Medical Sciences · 2023

DOI: 10.1002/kjm2.12636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2023. Verfasst von Jing Zhai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gansu provincial Hospital, Lanzhou, Gansu Province, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Tamoxifen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Much is known about the significance of lycorine, a natural alkaloid, in combating various types of cancer, including breast cancer (BC), but whether it participates in regulating tamoxifen (TAM) resistance and its underlying mechanism remain to be elucidated. Tamoxifen‐resistant (TAMR) BC cells were first established by continuously exposed to increasing concentrations of TAM. Levels of targeted gene including HOXD antisense growth‐associated lncRNA (HAGLR) and Vestigial like family member 4 (VGLL4) were analyzed by qRT‐PCR and western blot, respectively. Cell proliferation ability was assessed by MTT and EdU assays. Flow cytometry was carried out to evaluate the apoptosis. VGLL4 promoter methylation was examined using methylation specific PCR (MSP). The role of HAGLR acting on the expression of VGLL4 via DNA hypermethylation was confirmed by RNA immunoprecipitation (RIP). Here, we reported that lycorine administration reduced the survival ratio of TAMR BC cells, decreased the IC 50 of TAM, and strengthened TAM‐induced apoptosis. HAGLR, observed to be highly expressed in TAMR BC cells, was identified to be a downstream effector of lycorine, of which overexpression abolished lycorine‐mediated TAMR inhibition. VGLL4 served as a target of HAGLR in regulating lycorine‐mediated suppression on tamoxifen resistance of TAMR BC cells. Mechanistically, HAGLR epigenetically suppressed VGLL4 expression via DNA methyltransferase 1 (DNMT1)‐mediated DNA hypermethylation. Taken together, our data highlights the pivotal role of lycorine in TAM resistance of BC, which may provide a potential agent for improving the effectiveness and efficacy of BC resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTamoxifenFemaleHumansAntineoplastic Agents, HormonalApoptosisCell Line, TumorCell ProliferationDNADrug Resistance, NeoplasmEpigenesis, GeneticGene Expression Regulation, NeoplasticTranscription FactorsPhenanthridinesAmaryllidaceae AlkaloidsDNA (Cytosine-5-)-Methyltransferase 1

Stichwörter der Autor:innen

DNA hypermethylationHAGLRVGLL4lycorinetamoxifen resistance

Substanzen

Antineoplastic Agents, HormonalDNATamoxifenTranscription FactorslycorinePhenanthridinesAmaryllidaceae AlkaloidsVGLL4 protein, humanDNMT1 protein, humanDNA (Cytosine-5-)-Methyltransferase 1

Autor:innen und Institutionen

  • Department of Pharmacy, Gansu provincial Hospital, Lanzhou, Gansu Province, People's Republic of China.
  • Division of Oncology, Gansu Provincial Cancer Hospital, Lanzhou, Gansu Province, People's Republic of China.

ORCID-Profile: Lei Shi

Zitieren

APA

Zhai, J., Jiang, J. F., & Shi, L. (2023). Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR ‐mediated epigenetic suppression on VGLL4 by DNMT1. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12636

Vancouver

Zhai J, Jiang JF, Shi L. Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR ‐mediated epigenetic suppression on VGLL4 by DNMT1. The Kaohsiung Journal of Medical Sciences. 2023. doi:10.1002/kjm2.12636

BibTeX
@article{Zhai2023,
  author = {Zhai, Jing and Jiang, Jun-Feng and Shi, Lei},
  title = {Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR ‐mediated epigenetic suppression on VGLL4 by DNMT1},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  doi = {10.1002/kjm2.12636}
}
Kostenlos starten →